GOLDMAN SACHS GROUP INC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q2 2023$51,377
-84.1%
17,416
-86.6%
0.00%
Q1 2023$323,973
-39.9%
129,589
-23.8%
0.00%
Q4 2022$538,912
+13.7%
170,004
+6.5%
0.00%
Q3 2022$474,000
-77.7%
159,700
-77.1%
0.00%
Q2 2022$2,127,000
+96.2%
697,203
+767.8%
0.00%
Q1 2022$1,084,000
-15.6%
80,341
-18.6%
0.00%
Q4 2021$1,285,000
+59.2%
98,646
+14.7%
0.00%
Q3 2021$807,000
+34.5%
86,033
+46.9%
0.00%
Q2 2021$600,000
-45.8%
58,574
-2.5%
0.00%
Q1 2021$1,106,000
-66.7%
60,088
-66.6%
0.00%
-100.0%
Q3 2020$3,322,000179,9330.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$31,126,0003.38%
ACUTA CAPITAL PARTNERS, LLC 400,000$7,360,0002.65%
Logos Global Management LP 1,010,812$18,599,0001.82%
S Squared Technology, LLC 181,220$3,334,0001.58%
Avidity Partners Management LP 1,677,845$30,872,0000.85%
Perceptive Advisors 3,425,916$63,037,0000.80%
RTW INVESTMENTS, LP 2,652,553$48,807,0000.76%
Sofinnova Investments, Inc. 509,168$9,369,0000.56%
HighVista Strategies LLC 32,062$590,0000.44%
DAFNA Capital Management LLC 91,531$1,684,0000.40%
View complete list of ATHIRA PHARMA INC shareholders